Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study (JORTC-KMP03)
Yosuke Konno(Hokkaido University of Science), Hidemichi Watari(Hokkaido University of Science), Etsuko Fujimoto(Shikoku Cancer Center), Shunsuke Ohnishi(Hokkaido University), Shinichiro Minobe(National Hospital Organization Hokkaido Medical Center), Shin Nishio(Kurume University), Hideki Tokunaga(Tohoku University), Yoshio Yoshida(University of Fukui), Daito Noguchi(Jikei University School of Medicine), Eiji Nomura(Oji General Hospital), Wataru Kudaka(University of the Ryukyus), Kota Kihara, Shunsuke Oyamada(Research Organization of Information and Systems), Koji Nishino(Niigata University), Hisamori Kato(Kanagawa Prefectural Hospital Organization), Etsuko Miyagi(Yokohama City University), Takayuki Nagasawa(Iwate Medical University), Akira Kikuchi(Niigata Cancer Center Hospital), Takashi Iwata(Keio University), Yoshihito Yokoyama(Hirosaki University), Keisuke Ariyoshi(Japanese Foundation For Cancer Research), Tatsuru Ohara(St. Marianna University School of Medicine)
Cited by 2
Related Papers
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
|Oncotarget|2014|155
The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
|Journal of Translational Medicine|2014|129
MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
|Journal of Experimental & Clinical Cancer Research|2016|123